Amneal Pharmaceuticals, Inc. - Schedule 13D Filing

This filing is an amendment to a previous Schedule 13D filed on July 9, 2018, concerning the Class A Common Stock of Amneal Pharmaceuticals, Inc. Between November 14, 2024, and December 31, 2025, trusts controlled by Dipan Patel sold 6,924,729 shares of Class A Common Stock in open market transactions at prices ranging from $7.74 to $12.42 per share. As of December 31, 2025, Dipan Patel beneficially owns 16,904,263 shares, representing 5.4% of the outstanding Class A Common Stock. This ownership is based on 314,629,101 shares outstanding, as reported in the company's Form 10-K filed on February 27, 2026. Patel has sole voting and dispositive power over these shares. The filing is an amendment, designated as Amendment No. 5, and was signed on March 26, 2026.